AeroVironment
AVAV
$140.82
+0.36%
AeroVironment, Inc. is a defense technology provider that designs and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities across air, land, sea, space, and cyber domains. The company operates through two reportable segments — Autonomous Systems (AxS), which houses its legacy small uncrewed aircraft systems (UAS), loitering munitions, and uncrewed ground and underwater vehicles, and Space, Cyber and Directed Energy (SCDE), which was substantially expanded through the BlueHalo acquisition. AeroVironment is best understood as a pure-play, mid-cap defense technology disruptor rather than a diversified prime contractor, with a market capitalization of roughly $7.5-9.6 billion and approximately 4,091 employees, deriving the majority of revenue from domestic U.S. government customers. The current investor narrative is dominated by two competing forces: enthusiasm over a multiyear drone and counter-drone procurement upcycle — underscored by a $500 million U.S. Army counter-drone contract and a reported $2.7 billion backlog — versus deep skepticism about the BlueHalo integration, which has left the SCDE segment unprofitable and dragged consolidated GAAP earnings into the red. Recent headlines frame the debate sharply, with bulls calling the 38% drawdown overdone and bears pointing to thin contract revenue, negative EBITDA, and a valuation that still demands years of flawless execution.…
AVAV
AeroVironment
$140.82
Related headlines
Investment Opinion: Should I buy AVAV Today?
The synthesized recommendation is a Hold with a speculative tilt. The analyst consensus is a buy with a $219.35 average target, implying 44.3% upside, but the company's negative earnings, cash flow, and integration risks warrant caution. The core thesis is that AVAV is a high-risk, high-reward play on the defense tech upcycle, but current fundamentals do not justify a strong buy until profitability improves.
Supporting evidence includes: 1) Revenue growth of 133.3% year-over-year in Q4 FY2026, driven by acquisitions and organic demand; 2) A forward PE of 34.1x, which is reasonable if earnings materialize as analysts expect (EPS of $7.66); 3) A PEG ratio of 0.08, suggesting undervaluation relative to growth; 4) A $2.7 billion backlog and $500 million Army contract providing visibility. However, the company's gross margin of 25.3% is thin, and operating margin is -3.6%, highlighting execution issues. The PS ratio of 4.84 is above the industry average, and free cash flow is negative.
Key risks that could invalidate the thesis include: 1) Continued losses and cash burn, with no clear path to profitability; 2) Integration challenges with BlueHalo, which could delay synergies; 3) Dependence on government contracts and potential budget cuts. The rating would upgrade to Buy if the company demonstrates positive operating leverage and free cash flow, or if the stock drops below $120 (near the 52-week low) with improving fundamentals. It would downgrade to Sell if revenue growth decelerates below 20% or if cash burn accelerates. Relative to its history and peers, the stock appears undervalued on a PEG basis but overvalued on current earnings; thus, it is fairly valued with a speculative bias.
Sign up to view all
AVAV 12-Month Price Forecast
AVAV presents a high-risk, high-reward opportunity with significant upside if it successfully integrates BlueHalo and capitalizes on the defense upcycle. However, current fundamentals are weak, with negative earnings and cash flow, and the stock has been in a severe downtrend. The analyst consensus is bullish, but the market is skeptical. I would upgrade to bullish if the company shows tangible progress towards profitability, such as positive EBITDA and free cash flow, or if it announces major contract wins. I would downgrade to bearish if revenue growth stalls or if cash burn accelerates, leading to a liquidity crisis. The 12-month outlook is balanced, with a slight tilt towards the base case given the uncertainty.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AeroVironment's 12-month outlook, with a consensus price target around $219.35 and implied upside of +55.8% versus the current price.
Average Target
$219.35
0 analysts
Implied Upside
+55.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$149 - $315
Analyst target range
Bulls vs Bears: AVAV Investment Factors
The bull case rests on a multiyear defense procurement upcycle, a $2.7 billion backlog, and a $500 million Army contract that could drive substantial revenue growth. Analysts overwhelmingly rate the stock a buy with a $219.35 average target, implying 44% upside. However, the bear case is equally compelling: the company is unprofitable with negative free cash flow, the BlueHalo acquisition has yet to contribute positively, and the stock has been decimated, down nearly 50% over the past year. The most critical tension is whether the revenue growth from new contracts will translate into sustainable profitability and cash flow, or whether integration costs and thin margins will continue to erode shareholder value. Currently, the bear evidence appears stronger given the lack of earnings and cash flow, but the potential for a turnaround is significant if execution improves.
Bullish
- Analyst consensus buy with 44% upside: 19 analysts rate AVAV a buy (mean 1.6), with an average target price of $219.35 versus the current $152.05, implying 44.3% upside. The high target of $315 suggests some analysts see over 100% upside, reflecting confidence in the drone upcycle.
- Record backlog and Army contract: A reported $2.7 billion backlog and a $500 million U.S. Army counter-drone contract provide multiyear revenue visibility. These concrete awards underpin the bullish thesis that AVAV is at the start of a procurement supercycle.
- Revenue growth accelerating: Q4 FY2026 revenue grew 133.3% year-over-year to $641.6 million, driven by the BlueHalo acquisition and organic demand. This is a dramatic acceleration from prior quarters and demonstrates the scale of the opportunity.
- Fortress balance sheet: Debt-to-equity is only 0.19 and the current ratio is 4.30, indicating minimal leverage and ample liquidity. This provides flexibility to invest in growth and weather near-term losses without solvency risk.
Bearish
- Deep unprofitability and cash burn: The company has a trailing net margin of -13.4%, negative operating margin of -3.6%, and negative free cash flow of -$123.1 million. GAAP EPS is -$0.03, and EBITDA is deeply negative at -$248 million in the latest quarter.
- BlueHalo integration drags results: The SCDE segment remains unprofitable, with Q4 operating income of -$198.9 million and a net loss of $24.1 million. The acquisition has yet to deliver synergies and is a major overhang on the stock.
- Severe stock underperformance: AVAV is down 49.6% over the past year and 40.6% year-to-date, massively underperforming the S&P 500's +17.2% and +13.1% respectively. The relative strength over 1 year is -66.8%, indicating persistent weakness.
- Extreme volatility and drawdown: The stock has a beta of 1.41 and a max drawdown of -66.7%, with a 52-week range from $135.20 to $417.86. This volatility can lead to significant losses, as evidenced by the 38% drop from highs.
AVAV Technical Analysis
Beta
1.41
1.41x market volatility
Max Drawdown
-66.7%
Largest decline past year
52-Week Range
$135-$418
Price range past year
Annual Return
-60.9%
Cumulative gain past year
| Period | AVAV Return | S&P 500 |
|---|---|---|
| 1m | -3.1% | +0.6% |
| 3m | -26.2% | +3.3% |
| 6m | -23.6% | +17.4% |
| 1y | -60.9% | +15.0% |
| ytd | -45.0% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AVAV Fundamental Analysis
Quarterly Revenue
$480490000.0B
2026-08
Revenue YoY Growth
+5.7%
YoY Comparison
Gross Margin
25.9%
Latest Quarter
Free Cash Flow
$2188000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AVAV Overvalued?
PE
-36.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 28x~223x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-286.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. AVAV reported a net loss of $24.1 million in Q4 FY2026, with a net margin of -3.8% and negative free cash flow of -$123.1 million. The company's EBITDA was -$248 million, reflecting heavy integration costs and operational inefficiencies. With debt-to-equity at 0.19 and a current ratio of 4.30, liquidity is not an immediate concern, but continued cash burn could strain resources if profitability is not achieved soon. The SCDE segment, acquired via BlueHalo, remains unprofitable and is a key drag on consolidated results.
Market and competitive risks are elevated. The stock has a beta of 1.41, meaning it is more volatile than the broader market, and it has underperformed the S&P 500 by 66.8% over the past year. The defense sector is subject to political risks, including budget appropriations and shifting priorities. Recent news highlights rising oil prices and Treasury yields, which could pressure growth stock valuations. Additionally, competition in the drone and counter-drone space is intensifying, and AVAV's premium valuation (PS of 4.84) leaves little room for error. The company's reliance on U.S. government contracts also exposes it to policy changes and procurement delays.
In a worst-case scenario, if the BlueHalo integration fails to deliver and contract revenue remains thin, the stock could revisit its 52-week low of $135.20, representing a 11.1% decline from the current price of $152.05. However, given the max drawdown of -66.7% from the 52-week high of $417.86, a more severe downturn could see the stock fall below $100 if losses widen and analysts downgrade. The analyst low target of $148.57 is only 2.3% below the current price, suggesting limited downside according to some analysts, but the market's extreme pessimism could drive it lower. Investors could lose 30-40% from current levels in a bear scenario if the company fails to turn profitable and growth stalls.
FAQ
The key risks include: 1) Financial risk: negative net income of -$24.1 million in Q4 and negative free cash flow of -$123.1 million, which could lead to liquidity issues if sustained. 2) Integration risk: the BlueHalo acquisition has not yet contributed positively, and SCDE remains unprofitable, with operating losses of $198.9 million in Q4. 3) Competitive risk: the defense tech space is becoming crowded, and AVAV faces competition from larger primes and new entrants, which could pressure margins. 4) Macro risk: with a beta of 1.41, the stock is sensitive to market downturns, and rising interest rates could compress its valuation multiple. These risks are ranked from most to least severe, with financial and integration risks being the most immediate.
Our 12-month forecast has three scenarios: bull case (30% probability) with a target range of $250-$315, driven by successful integration and new contracts; base case (50% probability) with a target range of $180-$220, assuming steady growth but lingering profitability concerns; and bear case (20% probability) with a target range of $100-$148.57, if integration fails and cash burn continues. The base case is most likely, with the stock trading around the analyst average target of $219.35. The key assumption is that revenue grows 25% year-over-year and gross margins stabilize around 30%. However, given the high uncertainty, investors should be prepared for volatility.
AVAV's valuation is mixed. On a price-to-sales basis, it trades at 4.84x, which is above the aerospace and defense industry average of around 2-3x, suggesting a premium. However, its forward PE of 34.1x is reasonable for a company expected to grow earnings significantly, and its PEG ratio of 0.08 indicates undervaluation relative to growth. The market is pricing in high expectations for future growth, but current earnings are negative, making traditional metrics less reliable. Compared to its own history, the PS ratio is lower than in previous growth phases, but the stock is still not cheap. The valuation implies the market expects the company to execute flawlessly on its backlog and achieve profitability.
AVAV is a high-risk, high-reward investment that may be suitable for aggressive investors. The analyst consensus is a buy with a $219.35 average target, implying 44.3% upside from the current $152.05. However, the company is unprofitable with negative free cash flow of -$123.1 million and a net margin of -13.4%, which are significant red flags. The biggest downside risk is the potential for continued losses and integration issues with BlueHalo, which could drive the stock below its 52-week low of $135.20. For those with a long-term horizon and tolerance for volatility, it could be a good buy on dips, but it is not for the faint of heart.
AVAV is more suitable for long-term investment, given its growth stage and the time needed to realize synergies from the BlueHalo acquisition. The company pays no dividend, so returns depend entirely on capital appreciation. Its beta of 1.41 and max drawdown of -66.7% indicate high volatility, making it risky for short-term trading. Earnings visibility is low due to contract timing and integration costs, so quarterly results can be unpredictable. A minimum holding period of 3-5 years is recommended to allow the company to execute on its backlog and achieve profitability. Short-term traders might capitalize on volatility, but the risk of sharp losses is high.